Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pathogenesis of Wilson disease

IF. Scheiber, R. Brůha, P. Dušek,

. 2017 ; 142 (-) : 43-55.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010652

Grantová podpora
NV15-25602A MZ0 CEP - Centrální evidence projektů

Wilson disease is an autosomal-recessive disorder originating from a genetic defect in the copper-transporting ATPase ATP7B that is required for biliary copper secretion and loading of ceruloplasmin with copper. Impaired ATP7B function in Wilson disease results in excessive accumulation of copper in liver, brain, and other tissues. Toxic copper deposits may induce oxidative stress, modify expression of genes, directly inhibit proteins, and impair mitochondrial function, leading to hepatic, neuropsychiatric, renal, musculoskeletal, and other symptoms. Hepatocyte dysfunction initially manifests as steatosis and later may progress to other hepatic phenotypes such as acute liver failure, hepatitis, and fibrosis. In the brain, copper accumulates in astrocytes, leading to impairment of the blood-brain barrier and consequent damage to neurons and oligodendrocytes. Basal ganglia and brainstem are the brain regions with highest susceptibility to copper toxicity and their lesions lead to various combinations of movement and psychiatric disorders. This chapter will give an overview of the essential requirement of copper for biologic processes and the molecular mechanisms employed by cells to maintain their copper levels in a proper range. We will specify the physiologic functions of ATP7B and the consequences of its dysfunction and summarize the current knowledge on the pathogenesis of liver and neuropsychiatric disease. Finally, we will describe the consequences of copper overload in Wilson disease in other tissues.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010652
003      
CZ-PrNML
005      
20180413140134.0
007      
ta
008      
180404s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/B978-0-444-63625-6.00005-7 $2 doi
035    __
$a (PubMed)28433109
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Scheiber, Ivo Florin $u Department of Parasitology, Faculty of Science, Charles University, Prague, Czech Republic.
245    10
$a Pathogenesis of Wilson disease / $c IF. Scheiber, R. Brůha, P. Dušek,
520    9_
$a Wilson disease is an autosomal-recessive disorder originating from a genetic defect in the copper-transporting ATPase ATP7B that is required for biliary copper secretion and loading of ceruloplasmin with copper. Impaired ATP7B function in Wilson disease results in excessive accumulation of copper in liver, brain, and other tissues. Toxic copper deposits may induce oxidative stress, modify expression of genes, directly inhibit proteins, and impair mitochondrial function, leading to hepatic, neuropsychiatric, renal, musculoskeletal, and other symptoms. Hepatocyte dysfunction initially manifests as steatosis and later may progress to other hepatic phenotypes such as acute liver failure, hepatitis, and fibrosis. In the brain, copper accumulates in astrocytes, leading to impairment of the blood-brain barrier and consequent damage to neurons and oligodendrocytes. Basal ganglia and brainstem are the brain regions with highest susceptibility to copper toxicity and their lesions lead to various combinations of movement and psychiatric disorders. This chapter will give an overview of the essential requirement of copper for biologic processes and the molecular mechanisms employed by cells to maintain their copper levels in a proper range. We will specify the physiologic functions of ATP7B and the consequences of its dysfunction and summarize the current knowledge on the pathogenesis of liver and neuropsychiatric disease. Finally, we will describe the consequences of copper overload in Wilson disease in other tissues.
650    _2
$a hematoencefalická bariéra $7 D001812
650    _2
$a mozek $x metabolismus $7 D001921
650    _2
$a měď $x metabolismus $7 D003300
650    _2
$a ATPasy transportující měď $x genetika $x fyziologie $7 D000073840
650    _2
$a hepatolentikulární degenerace $x etiologie $x genetika $x metabolismus $7 D006527
650    _2
$a lidé $7 D006801
650    _2
$a duševní poruchy $x etiologie $7 D001523
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Brůha, Radan $u Fourth Department of Internal Medicine, Charles University in Prague, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Dušek, Petr $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic. Electronic address: pdusek@gmail.com.
773    0_
$w MED00191576 $t Handbook of clinical neurology $x 0072-9752 $g Roč. 142, č. - (2017), s. 43-55
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28433109 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180413140227 $b ABA008
999    __
$a ok $b bmc $g 1288137 $s 1007464
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 142 $c - $d 43-55 $i 0072-9752 $m Handbook of Clinical Neurology $n Handb Clin Neurol $x MED00191576
GRA    __
$a NV15-25602A $p MZ0
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...